1. Home
  2. CPIX vs TURN Comparison

CPIX vs TURN Comparison

Compare CPIX & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • TURN
  • Stock Information
  • Founded
  • CPIX 1999
  • TURN 1981
  • Country
  • CPIX United States
  • TURN United States
  • Employees
  • CPIX N/A
  • TURN N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • TURN Finance/Investors Services
  • Sector
  • CPIX Health Care
  • TURN Finance
  • Exchange
  • CPIX Nasdaq
  • TURN Nasdaq
  • Market Cap
  • CPIX 68.7M
  • TURN 39.6M
  • IPO Year
  • CPIX 2009
  • TURN N/A
  • Fundamental
  • Price
  • CPIX $5.15
  • TURN $4.12
  • Analyst Decision
  • CPIX
  • TURN
  • Analyst Count
  • CPIX 0
  • TURN 0
  • Target Price
  • CPIX N/A
  • TURN N/A
  • AVG Volume (30 Days)
  • CPIX 4.2M
  • TURN 48.4K
  • Earning Date
  • CPIX 03-04-2025
  • TURN 02-25-2025
  • Dividend Yield
  • CPIX N/A
  • TURN N/A
  • EPS Growth
  • CPIX N/A
  • TURN N/A
  • EPS
  • CPIX N/A
  • TURN N/A
  • Revenue
  • CPIX $36,785,442.00
  • TURN $194,813.00
  • Revenue This Year
  • CPIX N/A
  • TURN N/A
  • Revenue Next Year
  • CPIX N/A
  • TURN N/A
  • P/E Ratio
  • CPIX N/A
  • TURN N/A
  • Revenue Growth
  • CPIX N/A
  • TURN 6.32
  • 52 Week Low
  • CPIX $1.04
  • TURN $3.12
  • 52 Week High
  • CPIX $6.43
  • TURN $4.47
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 68.22
  • TURN 66.26
  • Support Level
  • CPIX $4.12
  • TURN $3.85
  • Resistance Level
  • CPIX $5.29
  • TURN $4.05
  • Average True Range (ATR)
  • CPIX 0.74
  • TURN 0.13
  • MACD
  • CPIX 0.17
  • TURN 0.00
  • Stochastic Oscillator
  • CPIX 70.57
  • TURN 95.71

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About TURN 180 Degree Capital Corp.

180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.

Share on Social Networks: